The Suppression of Peritoneal Cellular Immunity in Women With Endometriosis Could Be Restored After Gonadotropin Releasing Hormone Agonist Treatment
- 1 June 1996
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 35 (6) , 510-516
- https://doi.org/10.1111/j.1600-0897.1996.tb00050.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Increased expressions of CD69 and HLA-DR but not of CD25 or CD71 on endometrial T lymphocytes of nonpregnant womenHuman Immunology, 1995
- Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in cultureAmerican Journal of Obstetrics and Gynecology, 1995
- Correlation between Estradiol Serum Levels and NK Cell Activity in EndometriosisAnnals of the New York Academy of Sciences, 1994
- Neonatal treatment with luteinizing hormone-releasing hormone analogs alters peripheral lymphocyte subsets and cellular and humorally mediated immune responses in juvenile and adult male monkeysJournal of Clinical Endocrinology & Metabolism, 1994
- Lymphokine-Activated Killer Activity in Women with EndometriosisGynecologic and Obstetric Investigation, 1994
- Endometriotic Tissues Produce Immunosuppressive FactorsGynecologic and Obstetric Investigation, 1994
- Recombinant Interleukin‐2 Corrects In Vitro the Immunological Defect of EndometriosisAmerican Journal of Reproductive Immunology, 1993
- GnRH Agonist Induces Suppression of Lymphocyte Subpopulations in Secondary Lymphoid Tissues of Prepubertal Female MiceAmerican Journal of Reproductive Immunology, 1993
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathologyBJOG: An International Journal of Obstetrics and Gynaecology, 1986